Acadia Healthcare Company, INC 8-K filings

Acadia Healthcare reported second quarter 2026 results with revenue flat year-over-year, while net income and adjusted EBITDA saw significant decreases due to increased liability reserves and timing of supplemental payments.

Acadia Healthcare's subsidiary, Fashion Valley, faces a $105 million jury award in an employment-related retaliatory termination lawsuit.

Acadia Healthcare Company, Inc. stockholders elected three Class III directors and approved executive compensation and incentive plan amendments at the 2026 Annual Meeting.

Acadia Healthcare announced first quarter 2026 results, with revenue up 7.6% year-over-year, and raised full-year guidance for Adjusted EBITDA and Adjusted EPS.

Acadia Healthcare announces the appointment of David Duckworth as Interim CFO, succeeding Todd Young, and reaffirms its 2026 financial guidance.

Acadia Healthcare Company, Inc. announced the appointment of former Tenet Healthcare CFO Daniel Cancelmi to its Board of Directors, effective immediately, while director Wade Miquelon will retire at the 2026 Annual Meeting.

Acadia Healthcare announced a significant net loss for Q4 and full-year 2025 due to a goodwill impairment and legal settlements, alongside a reduced financial outlook for 2026.

Acadia Healthcare Company, Inc. announced the departure of CEO Christopher H. Hunter, detailing his separation benefits and ongoing obligations.

Acadia Healthcare Company, Inc. announced the immediate appointment of former CEO Debra K. Osteen, replacing Christopher H. Hunter, and reaffirmed its full-year 2025 financial guidance.

Acadia Healthcare Company, Inc. reaffirmed its 2025 financial guidance ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference.

Acadia Healthcare Company, Inc. has significantly reduced its 2025 financial guidance for Adjusted EBITDA and EPS following an annual actuarial review revealing a substantial increase in professional and general liability expenses.

Acadia Healthcare Company, Inc. has agreed to a $179 million settlement to resolve its previously disclosed securities litigation, with no impact on financial guidance.

Acadia Healthcare reported mixed third-quarter results with revenue growth but lowered its full-year guidance due to volume and rate pressures, while announcing a COO departure and strategic capital expenditure reductions.

Acadia Healthcare Company, Inc. announced the appointment of Todd Young, an executive with 25 years of financial and healthcare experience, as its new Chief Financial Officer, effective October 27, 2025.

Acadia Healthcare Company, Inc. announced preliminary 2026 guidance including a significant reduction in capital expenditures and planned bed additions, alongside interim third-quarter 2025 patient day growth.

Acadia Healthcare Company, Inc. announced solid second quarter 2025 financial results with significant revenue and Adjusted EBITDA growth, alongside an updated full-year guidance and a Chief Financial Officer transition.

Acadia Healthcare Company, Inc. announced that its stockholders approved all key proposals at the annual meeting on May 29, 2025, including the re-election of Class II directors, an amendment to the incentive compensation plan, and executive compensation.

Acadia Healthcare announced its first quarter 2025 financial results, reporting revenue of $770.5 million and affirming its full-year 2025 guidance.

Acadia Healthcare successfully priced and issued $550 million in senior notes due in 2033 to refinance existing debt, enhancing its financial flexibility.

Acadia Healthcare Company, Inc. enters into a new credit agreement providing a $1 billion revolving credit facility and a $650 million term loan facility, replacing its existing credit agreement.

Acadia Healthcare announces a 4.2% increase in revenue for Q4 2024, driven by growth in same-facility revenue and strategic bed expansion, alongside a new $300 million share repurchase authorization.

Acadia Healthcare announced a 3.2% year-over-year growth in same-facility patient days for the quarter ended December 31, 2024, aligning with previously communicated expectations.

Acadia Healthcare announced strong third-quarter results with revenue growth and increased adjusted EBITDA, while also revising its full-year 2024 financial guidance.

Acadia Healthcare is cooperating with federal authorities after receiving requests for information and subpoenas related to its admissions, length of stay, and billing practices.

Acadia Healthcare announced an 8.8% increase in revenue and a 7.6% increase in adjusted EBITDA for the second quarter of 2024, along with updated full-year guidance.

Acadia Healthcare has appointed Dr. Nasser Khan as Chief Operating Officer, effective June 30, 2024, while also announcing the retirement of John Hollinsworth and the declassification of its Board of Directors.

Acadia Healthcare announced a 9.1% revenue increase and a 14.9% adjusted EBITDA increase for the first quarter of 2024, while also affirming its full-year 2024 guidance.

Acadia Healthcare announced a 10% revenue increase in Q4 2023, alongside significant growth in adjusted EBITDA and strategic expansions, setting a positive outlook for 2024.

Acadia Healthcare Company, Inc. has amended its credit agreement to include an additional $350 million in senior secured term loans for general corporate purposes.